Who will pay for the next Covid vaccines?

Behind the Money

Topher Forhecz

Markets, Investing, News, Banking, Finance, Business, Business News, Crypto

4.4 • 350 Ratings

🗓️ 28 September 2022

⏱️ 19 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

As the rollout of bivalent boosters for Covid-19 continues, experts are concerned that the US isn’t doing enough to support the development of the next wave of vaccines and treatments that the world needs. In this week’s episode, we hear from White House Covid coordinator Ashish Jha, professor of molecular medicine and cardiologist Eric Topol and the FT’s US pharmaceuticals correspondent Jamie Smyth on what the future of Covid vaccines could and should look like.

- - - - - - - - - - - - - - - - - - - - - - - - - -

For further reading:

Investors ditch vaccine stocks after Joe Biden says ‘pandemic is over’

Joe Biden’s Covid-19 tsar warns millions risk losing access to treatment

- - - - - - - - - - - - - - - - - - - - - - - - - -

On Twitter, follow Jamie Smyth (@JamieSmythF) and Michela Tindera (@mtindera07)

Read a transcript of this episode on FT.com

Hosted on Acast. See acast.com/privacy for more information.

Transcript

Click on a timestamp to play from that location

0:00.0	Am I missing anything? Is this the right decision?
0:02.0	Could it be a alternative?
0:04.0	Am I too late?
0:05.0	Find clarity in your investment decision-making.
0:08.0	Manage your portfolio for sustainable growth
0:11.0	and regulatory alignment
0:12.0	with the ultimate blend of powerful AI and
0:14.6	industry expertise.
0:16.5	Reduce risk, meet your sustainability goals and push the boundaries of possibilities based on
0:21.1	facts, not opinions.
0:23.0	Clarity AI scaling human decisions through tech.
0:26.6	Visit clarity.
0:28.3	And take action today.
0:29.9	The new bivalent booster vaccines for COVID are available now, but the path to making these
0:38.1	ready for adults earlier this month wasn't easy.
0:41.9	The administration have had to borrow, beg and steal money from
0:45.5	different programs to actually be able to purchase the new bivalent boosters from
0:51.2	Pfizer and Moderna.
0:53.0	That's Jamie Smith, the F.T.'s U.S. Pharmaceutical correspondent.
0:58.0	They took money from funds that were aimed towards building stockpiles of tests,
1:05.1	building stockpiles of personal protective equipment.
1:09.3	So that money's been spent on the new boosters.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Topher Forhecz, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Topher Forhecz and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.